Presilium Private Wealth’s Merck MRK Stock Holding History

Presilium Private Wealth’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$653K	Buy	5,084 +1,710	+51%	+$200K	0.1%	52
2026 Q1	$406K	Sell	3,374 -1,275	-27%	-$147K	0.07%	59
2025 Q4	$489K	Hold	4,649	–	–	0.09%	53
2025 Q3	$390K	Sell	4,649 -185	-4%	-$15.2K	0.07%	60
2025 Q2	$383K	Buy	4,834 +1,314	+37%	+$104K	0.08%	58
2025 Q1	$316K	Sell	3,520 -50	-1%	-$4.67K	0.07%	62
2024 Q4	$355K	Hold	3,570	–	–	0.08%	63
2024 Q3	$405K	Sell	3,570 -782	-18%	-$92.9K	0.09%	58
2024 Q2	$539K	Sell	4,352 -955	-18%	-$123K	0.14%	52
2024 Q1	$700K	Buy	5,307 +770	+17%	+$94.9K	0.19%	45
2023 Q4	$495K	Sell	4,537 -481	-10%	-$49.9K	0.14%	52
2023 Q3	$517K	Sell	5,018 -1,008	-17%	-$109K	0.16%	36
2023 Q2	$695K	Sell	6,026 -572	-9%	-$64.9K	0.24%	28
2023 Q1	$702K	Buy	6,598 +598	+10%	+$64.6K	0.27%	27
2022 Q4	$666K	Buy	+6,000	New	+$613K	0.28%	27

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Presilium Private Wealth's MRK Position: Q2 2026 in Review

Presilium Private Wealth increased its Merck (MRK) stake by 51% in Q2 2026, buying an estimated $200K and bringing the position to 5,084 shares worth $653K. The position accounts for 0.1% of the portfolio, ranked #52.

Presilium Private Wealth first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. The position peaked at $702K in Q1 2023. 3,814 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Presilium Private Wealth held 5,084 shares of Merck worth $653K as of Q2 2026.
Presilium Private Wealth bought 1,710 Merck shares in Q2 2026, an estimated $200K.
Merck made up 0.1% of Presilium Private Wealth's portfolio in Q2 2026, its #52 holding.
Presilium Private Wealth first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
Presilium Private Wealth's Merck position peaked at $702K in Q1 2023.
3,814 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Presilium Private Wealth's 13F filing for Q2 2026, filed 22 Jul 2026.